ProfileGDS4718 / 221805_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 14% 16% 81% 11% 15% 7% 10% 15% 17% 17% 24% 17% 10% 7% 9% 27% 24% 6% 7% 15% 16% 15% 16% 13% 14% 9% 11% 8% 19% 8% 22% 13% 17% 12% 13% 10% 11% 18% 13% 79% 14% 6% 23% 10% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]3.9197514
GSM549102patient 115, normal, homogenized [OPG study]4.0193216
GSM549104patient 119, normal, homogenized [OPG study]8.0429581
GSM549108patient 138, normal, homogenized [OPG study]3.8572111
GSM549119patient 077, normal, homogenized [OPG study]3.9841415
GSM549133patient 032, cancer, homogenized [OPG study]3.648617
GSM549139patient 042, cancer, homogenized [OPG study]3.7597110
GSM549099patient 107, normal, homogenized [OPG study]3.9830115
GSM549109patient 139, normal, homogenized [OPG study]4.0436617
GSM549110patient 046, normal, homogenized [OPG study]4.0264817
GSM549114patient 063, normal, homogenized [OPG study]4.2504124
GSM549122patient 082, normal, homogenized [OPG study]4.0466617
GSM549134patient 033, cancer, homogenized [OPG study]3.7842710
GSM549136patient 036, cancer, homogenized [OPG study]3.628937
GSM549140patient 044, cancer, homogenized [OPG study]3.716939
GSM549111patient 047, normal, homogenized [OPG study]4.3906827
GSM549113patient 057, normal, homogenized [OPG study]4.2422824
GSM549132patient 031, cancer, homogenized [OPG study]3.604536
GSM549137patient 038, cancer, homogenized [OPG study]3.678167
GSM549142patient 047, cancer, homogenized [OPG study]4.0201715
GSM549100patient 110, normal, homogenized [OPG study]4.0071516
GSM549107patient 135, normal, homogenized [OPG study]3.9312615
GSM549115patient 068, normal, homogenized [OPG study]3.9679316
GSM549116patient 072, normal, homogenized [OPG study]3.8802113
GSM549120patient 078, normal, homogenized [OPG study]3.9231414
GSM549131patient 030, cancer, homogenized [OPG study]3.724189
GSM549118patient 074, normal, homogenized [OPG study]3.8220811
GSM549129patient 027, cancer, homogenized [OPG study]3.732028
GSM549123patient 088, normal, homogenized [OPG study]4.0908119
GSM549124patient 006, cancer, homogenized [OPG study]3.728558
GSM549126patient 015, cancer, homogenized [OPG study]4.2007422
GSM549128patient 025, cancer, homogenized [OPG study]3.8769413
GSM549103patient 117, normal, homogenized [OPG study]4.0578517
GSM549117patient 073, normal, homogenized [OPG study]3.8545412
GSM549138patient 041, cancer, homogenized [OPG study]3.8822613
GSM549141patient 045, cancer, homogenized [OPG study]3.7411910
GSM549130patient 028, cancer, homogenized [OPG study]3.8351211
GSM549101patient 111, normal, homogenized [OPG study]4.0901918
GSM549105patient 128, normal, homogenized [OPG study]3.8946713
GSM549106patient 134, normal, homogenized [OPG study]7.9463379
GSM549112patient 048, normal, homogenized [OPG study]3.9101414
GSM549125patient 011, cancer, homogenized [OPG study]3.638996
GSM549127patient 024, cancer, homogenized [OPG study]4.2239323
GSM549135patient 035, cancer, homogenized [OPG study]3.7193110